NSC-319726

CAS No. 71555-25-4

NSC-319726( NSC319726 )

Catalog No. M15734 CAS No. 71555-25-4

NSC-319726 (NSC319726) is an allele-specific p53 mutant reactivator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 54 In Stock
2MG 30 In Stock
5MG 49 In Stock
10MG 81 In Stock
25MG 151 In Stock
50MG 268 In Stock
100MG 456 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NSC-319726
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC-319726 (NSC319726) is an allele-specific p53 mutant reactivator.
  • Description
    NSC-319726 (NSC319726) is an allele-specific p53 mutant reactivator; restores WT structure and function to the p53(R175) mutant; kills p53(R172H) knockin mice with extensive apoptosis and inhibits xenograft tumor growth in a 175-allele-specific mutant p53-dependent manner.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC319726
  • Pathway
    Apoptosis
  • Target
    MDM2-p53
  • Recptor
    p53(R175)
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    71555-25-4
  • Formula Weight
    234.3207
  • Molecular Formula
    C11H14N4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 27.5 mg/mL
  • SMILES
    C/C(=N\NC(=S)N1CCC1)/C2=CC=CC=N2
  • Chemical Name
    1-Azetidinecarbothioic acid, 2-[1-(2-pyridinyl)ethylidene]hydrazide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yu X, et al. Cancer Cell. 2012 May 15;21(5):614-25. 2. Yu X, et al. Oncotarget. 2014 Oct 15;5(19):8879-92. 3. Yu X, et al. Mol Pharmacol. 2017 Jun;91(6):567-575. 4.?Shimada K, et al. Cell Chem Biol. 2018 May 17;25(5):585-594.e7.
molnova catalog
related products
  • YH239-EE

    YH239-EE is the ethyl ester of YH239, which is a highly potent, selective MDM2-p53 antagonist with Ki of 300 nM.

  • NSC-59984

    A small molecule that both destabilize mutant p53 and restores wild-type p53 pathway in cancer cells.

  • RETRA

    RETRA is a small molecule mutant p53 reactivator that activates a set of p53-regulated genes and specifically suppresses mutant p53-bearing tumor cells in vitro and in mouse xenograft.